Metraipolis › archive › dc_f29aede0880a

Myofibroblastic Proliferation as a Secondary Malignancy From Radioactive Iodine Treatment for Thyroid Carcinoma: A Case Report — Europe PMC PMID:40964575

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40964575
DOI
10.7759/cureus.90257
License (as archived)
solo-consultazione
Archived
2026-11-10T14:09:06.608Z
SHA-256 of the archived text
556cd3d769b31c05ba528283b8cdbd444b4219e03ef0cac70d774dd2c6284bef
Stable URL of this page
https://metraipolis.com/documento/dc_f29aede0880a

How to cite

Myofibroblastic Proliferation as a Secondary Malignancy From Radioactive Iodine Treatment for Thyroid Carcinoma: A Case Report — Europe PMC PMID:40964575 — Europe PMC (en), https://europepmc.org/article/MED/40964575 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f29aede0880a (Metraipolis archive dc_f29aede0880a, sha256 556cd3d769b31c05ba528283b8cdbd444b4219e03ef0cac70d774dd2c6284bef)
BibTeX
@misc{dcf29aede0880a,
  title = {Myofibroblastic Proliferation as a Secondary Malignancy From Radioactive Iodine Treatment for Thyroid Carcinoma: A Case Report — Europe PMC PMID:40964575},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40964575},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f29aede0880a; sha256 556cd3d769b31c05ba528283b8cdbd444b4219e03ef0cac70d774dd2c6284bef},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40964575. Agents can read the archived copy with the MCP tool read_document.